Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag for Platelet Engraftment After ASCT in Children With Neuroblastoma
NCT06818916Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Jun 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hetrombopag in Delayed platelet engraftment (DPE), sponsored by Beijing Children's Hospital. Primary endpoint: Accumulated platelet engraftment rate at 60 days. Started Jun 2024; status: recruiting.
02
Drugs
hetrombopag
03
Conditions
Delayed platelet engraftment (DPE)
Beyond the preview
Go deeper on NCT06818916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06818916.